注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Vaxart Inc是一家临床阶段的生物技术公司,主要开发基于其载体-佐剂-抗原标准化技术(VAAST)口服疫苗平台的口服重组疫苗。该公司的项目包括旨在预防冠状病毒、诺如病毒、季节性流感和呼吸道合胞病毒(RSV)的片剂疫苗,以及人乳头瘤病毒(HPV)的治疗性疫苗。该公司的产品线包括诺如病毒疫苗,一种口服片剂疫苗,该疫苗正处于Ib期临床试验中;针对GI.1和 GII.4株诺如病毒株的二价口服片剂疫苗;流感疫苗,用于治疗H1流感感染的II期临床试验;呼吸道合胞病毒疫苗;和冠状病毒疫苗,该疫苗正处于治疗SARS-CoV-2感染的II期临床试验中。该公司还在开发针对人乳头瘤病毒引起的宫颈癌和不典型增生的治疗性疫苗。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Michael J. Finney | 65 | 2018 | Chairman of the Board |
David E. Wheadon | 65 | 2021 | Independent Lead Director |
James Robinson | 63 | - | Member of Manufacturing & Quality Advisory Board |
Steven Lo | 57 | 2024 | President, CEO & Director |
Stefan Gravenstein | - | 2021 | Member of Scientific & Clinical Advisory Board |
Gregory C. Gray | - | 2021 | Member of Scientific & Clinical Advisory Board |
John F. Carpenter | - | 2021 | Member of Manufacturing & Quality?Advisory?Board |
Robert B. Belshe | - | 2021 | Member of Scientific & Clinical Advisory Board |
Benjamin J. Del Tito | 68 | 2021 | Member of Manufacturing & Quality?Advisory?Board |
George R. Siber | 79 | 2021 | Member of Scientific & Clinical Advisory Board |
Harry B. Greenberg | - | 2021 | Member of Scientific & Clinical Advisory Board |
William Mark Watson | 74 | 2022 | Director |
Elaine J. Heron | 76 | 2022 | Director |
Ralph Baric | - | 2021 | Member of Scientific & Clinical Advisory Board |
Marion Pepper | - | 2021 | Member of Scientific & Clinical Advisory Board |
Vijay Jethwa | - | 2021 | Member of Manufacturing & Quality?Advisory?Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核